A single healthcare provider’s judgment would determine whether an abortion after viability is legal in all 50 states under H.R. 12, according to the text of the bill.
That provision sits at the front of an 84-page health policy agenda now circulating among House Democrats.
The bill carries the formal title Women’s Health Protection Act. Rep. Judy Chu, a California Democrat, sponsors it, and more than 200 of her Democratic colleagues have signed on as cosponsors.
Under the measure, abortions after viability would receive legal protection whenever one provider decides the procedure is “necessary for life or health.”
The bill itself sets no second opinion or review as a requirement, according to the description of its text.
Viability refers to the stage at which a baby can survive outside the mother’s womb.
The legislation explicitly prohibits governmental restrictions on abortion both before and after that stage.
Pro-life advocates focus their objections on the word “health.”
They argue that the exception lacks specific medical definitions or limitations, and they say that gap amounts to a federal mandate for unrestricted abortion through all nine months of pregnancy.
The agenda itself came from a health policy working group that House Minority Leader Hakeem Jeffries, a New York Democrat, established.
The group produced the document as an internal guide to the caucus’s legislative priorities in the event Democrats win a congressional majority.
A September memo from the group frames the ambitions behind the plan.
“Undoing H.R. 1 is the floor, but not the ceiling,” the memo states, referring to a rollback of Republican-led healthcare policies.
The memo also describes a “broad consensus” on abortion policy within the caucus. The agenda places H.R. 12 at the center of its health priorities.
The bill’s effects would reach well beyond Capitol Hill.
It would override the pro-life laws of every state that currently protects unborn children from abortion under the Supreme Court’s decision in Dobbs.
That ruling returned the authority to regulate abortion to the states.
Since then, individual state legislatures have written their own laws, and the Women’s Health Protection Act would replace those state-by-state differences with a single federal standard.
Enforcement is the second major point of contention. Opponents of the bill say its provisions authorize the Department of Justice to file lawsuits against state governments.
Abortion centers and individual abortion providers would hold that same power, according to opponents.
Private businesses and practitioners could therefore take a state to court directly over its abortion laws.
Critics contend those suits would completely override standard statutory immunity, the legal shield that ordinarily limits when a state can be sued.
They say the arrangement would systematically dismantle established state-level protections.
The document does not carry the force of law. It lays out priorities, and its practical impact depends entirely on the outcome of congressional elections.
H.R. 12 has not yet passed. Its backers number more than 200 in the House, which gives the bill a large bloc of support inside the Democratic caucus before any majority is won.
The working group’s memo and the 84-page agenda together offer an early look at how House Democrats would organize their first legislative moves on health care.
Abortion appears at the front of that list.
Supporters of the Women’s Health Protection Act have not been quoted in the document as described here, and the characterizations of the bill’s reach come from the text itself and from pro-life critics who have reviewed it.
